This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Corin Perrin
Analytical Development Manager at Axolabs
Speaker

Profile

Corin Perrin is currently Analytical Development Manager at LGC Axolabs Petaluma, where she leads a team providing comprehensive analytical support for oligonucleotide-based therapeutics. She has over ten years of experience in the pharmaceutical industry, including prior roles in GMP manufacturing, analytical development, and technical leadership. Her work includes Phase-appropriate analytical development and validation for pre-clinical through Phase III studies, with a focus on and preparing high-quality regulatory documentation. Corin is passionate about advancing Chemistry, Manufacturing, and Control (CMC) strategy and is currently pursuing an MBA to further integrate scientific and business leadership in her career.

Agenda Sessions

  • Chromatographic Tools for the Bioanalysis of Oligonucleotide Therapeutics

    12:05pm